NCT07048353 CD30 CAR-T in the Treatment of CD30 Positive Lymphoma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07032103 Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV Status RECRUITING Phase N/A
NCT07030699 A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma Status WITHDRAWN Phase PHASE2
NCT07020260 The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07015242 A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma Status RECRUITING Phase PHASE2
NCT07014293 Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors Status NOT_YET_RECRUITING Phase NA
NCT07013435 A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship Status NOT_YET_RECRUITING Phase NA
NCT06971523 A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies Status RECRUITING Phase PHASE1/PHASE2
NCT06967038 Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome Status RECRUITING Phase PHASE1/PHASE2
NCT06954805 Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Status RECRUITING Phase PHASE2
NCT06944119 Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06923397 Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial Status RECRUITING Phase NA
NCT06915246 A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma Status RECRUITING Phase PHASE2
NCT06895538 Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy Status RECRUITING Phase N/A
NCT06892119 Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT06883526 Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT06867536 Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden Status RECRUITING Phase PHASE2